Moderna Inc (NAS:MRNA)
$ 132.68 3.62 (2.8%) Market Cap: 50.83 Bil Enterprise Value: 42.17 Bil PE Ratio: 0 PB Ratio: 3.86 GF Score: 67/100

Moderna, Inc. - Special Call Transcript

Mar 30, 2020 / 12:00PM GMT
Release Date Price: $30.48 (+1.43%)
Lavina Talukdar
Moderna, Inc. - Head of IR

Good morning, and welcome to the Moderna's conference call where we will discuss the impact of the COVID-19 on business operations and clinical program development. You can access the press release issued last night by going to the Investors section of our website.

Today on this call, we have Stéphane Bancel, Chief Executive Officer; Stephen Hoge, President; Tal Zaks, Chief Medical Officer; Lorence Kim, Chief Financial Officer; Juan Andres, Chief Technical Operations and Quality Officer; and Tracey Franklin, Chief Human Resources Officer.

Before we begin, I would like to remind everyone that this conference call will include forward-looking statements. Please see the bottom of the issued press release and our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to update or revise the information provided on this call as a result of new information or future results or developments.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot